<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Verhoeven, G.T.</title>
    <link>http://repub.eur.nl/res/aut/2565/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>A high prevalence of culture-positive extrapulmonary tuberculosis in a large Dutch teaching hospital (Article)</title>
      <link>http://repub.eur.nl/res/pub/10136/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: In the Netherlands the incidence of tuberculosis (TB) has
      increased during the last decade. Growing immigration and international
      travel were important determining factors. To determine if this has
      resulted in altered clinical manifestations of the disease, we assessed
      the clinical spectrum of all TB cases diagnosed at our hospital in the
      period 1994 to 2000. METHODS: All culture-proven TB cases during the study
      period were retrospectively reviewed for clinical and demographic data.
      RESULTS: Sixty-five patients were identified. Solitary pulmonary TB was
      diagnosed in 33.9%, extrapulmonary TB in 51.8% and combined pulmonary and
      extrapulmonary TB in 14.3% of all cases. Patients were of foreign descent
      in 78.6% of all cases. Incidence peaked between 15 to 45 years. Decreased
      immunity was an important determining factor in the older patients.
      Presenting symptoms were mostly aspecific causing an important doctor's
      delay in establishing the diagnosis in 25%. Mortality was 3.6% and
      isoniazid resistance 3.6% CONCLUSIONS: Our data suggest an increase in the
      percentage of extrapulmonary TB concomitantly with an increasing
      percentage of patients of foreign descent. Because of aspecific presenting
      symptoms, TB was often diagnosed late. Treatment is mainly hindered by
      non-compliance and a high index of suspicion is necessary in making the
      diagnosis.</description>
    </item> <item>
      <title>Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness (Article)</title>
      <link>http://repub.eur.nl/res/pub/8479/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Treatment of chronic obstructive pulmonary disease (COPD) with
      inhaled corticosteroids does not appear to be as effective as similar
      treatment of asthma. It seems that only certain subgroups of patients with
      COPD benefit from steroid treatment. A study was undertaken to examine
      whether inhaled fluticasone propionate (FP) had an effect on lung function
      and on indices of inflammation in a subgroup of COPD patients with
      bronchial hyperresponsiveness (BHR). METHODS: Twenty three patients with
      COPD were studied. Patients had to be persistent current smokers between
      40 and 70 years of age. Non-specific BHR was defined as a PC(20) for
      histamine of &lt;or=8 mg/ml. Patients received either 2 x 500 microg FP or
      placebo for 6 months. Expiratory volumes were measured at monthly visits,
      BHR was determined at the start of the study and after 3 and 6 months, and
      bronchial biopsy specimens were taken at the start and after 6 months of
      treatment. Biopsy specimens from asymptomatic smokers served as controls.
      RESULTS: In contrast to asthma, indices of BHR were not significantly
      influenced by treatment with FP. Forced expiratory volume in 1 second
      (FEV(1)) showed a steep decline in the placebo group but remained stable
      in patients treated with FP. FEV(1)/FVC, and maximal expiratory flows at
      50% and 25% FVC (MEF(50), MEF(25)) were significantly increased in the FP
      treated patients compared with the placebo group. Biopsy specimens were
      analysed for the presence of CD3+, CD4+, CD8+, MBP+, CD15+, CD68+, CD1a,
      and tryptase cells. FP treatment resulted in marginal reductions in these
      indices of inflammation. CONCLUSION: In patients with COPD and BHR, FP has
      a positive effect on indices of lung function compared with placebo.
      Bronchial inflammation analysed in bronchial biopsy specimens is only
      marginally reduced.</description>
    </item> <item>
      <title>Bronchial hyperresponsiveness in chronic obstructive pulmonary disease : functional and inflammatory characteristics : effects of treatment with inhaled fluticasone propionate (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/23395/</link>
      <pubDate>2001-05-16T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Influence of lung parenchymal destruction on the different indexes of the methacholine dose-response curve in COPD patients (Article)</title>
      <link>http://repub.eur.nl/res/pub/9317/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>STUDY OBJECTIVES: The interpretation of nonspecific bronchial provocation
          dose-response curves in COPD is still a matter of debate. Bronchial
          hyperresponsiveness (BHR) in patients with COPD could be influenced by the
          destruction of the parenchyma and the augmented mechanical behavior of the
          lung. Therefore, we studied the interrelationships between indexes of BHR,
          on the one hand, and markers of lung parenchymal destruction, on the
          other. PATIENTS AND METHODS: COPD patients were selected by clinical
          symptoms, evidence of chronic, nonreversible airways obstruction, and BHR,
          which was defined as a provocative dose of a substance (histamine) causing
          a 20% fall in FEV(1) (PC(20)) of &lt;/= 8 mg/mL. BHR was subsequently studied
          by methacholine dose-response curves to which a sigmoid model was fitted
          for the estimation of plateau values and reactivity. Model fits of
          quasi-static lung pressure-volume (PV) curves yielded static lung
          compliance (Cstat), the exponential factor (KE) and elastic recoil at 90%
          of total lung capacity (P90TLC). Carbon monoxide (CO) transfer was
          measured with the standard single-breath method. RESULTS: Twenty-four
          patients were included in the study, and reliable PV data could be
          obtained from 19. The following mean values ( +/- SD) were taken: FEV(1),
          65 +/- 12% of predicted; reversibility, 5.6 +/- 3.1% of predicted; the
          PC(20) for methacholine, 4.3 +/- 5.2 mg/mL; reactivity, 11.0 +/- 5.6%
          FEV(1)/doubling dose; plateau, 48.8 +/- 17.4% FEV(1); transfer factor,
          76.7 +/- 17.9% of predicted; transfer coefficient for carbon monoxide
          (KCO), 85.9 +/- 22.6% of predicted; Cstat, 4.28 +/- 2.8 kPa; shape factor
          (KE), 1.9 +/- 1.5 kPa; and P90TLC, 1.1 +/- 0.8 kPa. We confirmed earlier
          reported relationships between Cstat, on the one hand, and KE (p &lt;
          0.0001), P90TLC (p = 0.0012), and KCO percent predicted (p = 0.006), on
          the other hand. The indexes of the methacholine provocation test were not
          related to any parameter of lung elasticity and CO transfer. CONCLUSION:
          BHR in COPD patients who smoke most probably is determined by airways
          pathology rather than by the augmented mechanical behavior caused by lung
          parenchymal destruction.</description>
    </item> <item>
      <title>Anesthesia for endobronchial laser surgery: a modified technique (Article)</title>
      <link>http://repub.eur.nl/res/pub/9009/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>We describe a technique for endobronchial surgery with the
          neodynium:yttium-aluminum-garnet laser, in which an insufflation catheter
          with side holes placed into the contralateral mainstem bronchus is used
          for high-frequency positive pressure ventilation. Thirty-five patients (45
          procedures) were treated during general anesthesia using a rigid
          bronchoscope in combination with a fiberoptic bronchoscope.
          Perioperatively, oxygen saturation (SaO2), mean arterial pressure, and
          heart rate were recorded. SaO2 during the recovery period was comparable
          to that during the intraoperative period but was significantly (P &lt; 0.05)
          higher than that before the induction of anesthesia. There was a
          considerable (&gt; or = 5%) increase in SaO2 at the end of the treatment in
          six patients, which indicates that the recanalization of the treated
          airway was successful. Our data support the assumption that, during
          endobronchial resection, selective ventilation of the nonaffected lung was
          adequate; in addition, subcarinal placement of the insufflation catheter
          with side holes was advantageous. We conclude that this technique
          contributes to the prevention of lung complications during endobronchial
          laser surgery. Implications: We describe a technique in which an
          insufflation catheter with side holes placed into the contralateral
          mainstem bronchus largely prevented inhalation of laser smoke and
          aspiration of blood and debris.</description>
    </item>
  </channel>
</rss>